Voyager Therapeutics
Voyager Therapeutics is seeking a Scientist I, Protein Science, to support the discovery and development of biotherapeutics by purifying and characterizing complex proteins. The role involves collaboration within the protein science group and with other teams to generate protein reagents and biologic candidates.
Headquarters
Lexington, Massachusetts, United States
Company Size
51-200 employees
Founded
2014
Voyager Therapeutics (Nasdaq: VYGR) is a biotechnology company dedicated to leveraging human genetics to treat and ultimately cure neurological diseases. Their pipeline includes genetic medicines for Alzheimer's disease, ALS, Parkinson's disease, and other CNS conditions, with multiple Alzheimer's programs currently in development. Many of their programs are derived from their proprietary TRACER™ AAV capsid discovery platform, which enables intravenous delivery of gene therapies across the blood-brain barrier.
H.C. Wainwright reiterates Voyager Therapeutics stock rating at buy
12 hours ago
Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Voyager Therapeutics (VYGR) and Structure Therapeutics, Inc. Sponsored ADR (GPCR)
14 hours ago
Voyager Therapeutics' (VYGR) "Buy" Rating Reaffirmed at HC Wainwright
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Voyager Therapeutics.
85% above the average for this role
Voyager Therapeutics (VYGR): Analyst Reiterates Buy Rating and M
1 day ago
Protein Reagents Scientist
Regeneron Pharmaceuticals
Associate Scientist, Protein Sciences
CytomX Therapeutics
ASSOCIATE/RESEARCH SCIENTIST - PROTEIN SCIENCES
MAXION TECHNOLOGIES
Research Associate I/II
Ring Therapeutics
Associate Scientist, Protein Development
Regeneron Pharmaceuticals
Senior Scientist – Protein Science
AstraZeneca